These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3953559)

  • 1. Autologous survival of cyanate-treated cryopreserved sickle erythrocytes.
    Castro O; Rana SR; Poillon WN
    Am J Hematol; 1986 Apr; 21(4):409-13. PubMed ID: 3953559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreservation of cyanate-treated sickle erythrocytes.
    Castro O
    Cryobiology; 1982 Aug; 19(4):339-45. PubMed ID: 7116897
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG; Miller DR; Cerami A; Manning JM
    J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
    Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
    J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freeze preservation of sickle erythrocytes.
    Castro O; Hardy KP; Winter WP; Hornblower M; Meryman HT
    Am J Hematol; 1981; 10(3):297-304. PubMed ID: 7246537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cryopreservation of red cells from patients with sickle cell disease.
    Castro OL
    Transfusion; 1985; 25(1):70-2. PubMed ID: 3969705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransfusion survival of red cells frozen for 8 weeks after 42-day liquid storage in AS-3.
    Rathbun EJ; Nelson EJ; Davey RJ
    Transfusion; 1989; 29(3):213-7. PubMed ID: 2922788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased life span and membrane damage of carbamylated erythrocytes in vitro.
    Lane TA; Burka ER
    Blood; 1976 Jun; 47(6):909-17. PubMed ID: 1276471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of phosphoenolpyruvate into the preparation of frozen and thawed red cells.
    Shiraki H; Ohyama M; Hamasaki N; Maeda Y
    Biomed Biochim Acta; 1990; 49(2-3):S204-7. PubMed ID: 2386507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.
    Deiderich DA; Trueworthy RC; Gill P; Cader AM; Larsen WE
    J Clin Invest; 1976 Sep; 58(3):642-53. PubMed ID: 956392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phosphoenolpyruvate on metabolic and morphological recovery of red cells after prolonged liquid storage and subsequent freezing in glycerol medium.
    Ohyama M; Aritake H; Shiraki H; Hamasaki N; Maeda Y
    Cryobiology; 1992 Jun; 29(3):342-6. PubMed ID: 1499319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viability and function of stored sickle erythrocytes.
    Castro O
    Transfusion; 1980; 20(6):695-703. PubMed ID: 7434453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired tissue oxygenation in cyanate-treated animals.
    Balcerzak SP; Melaragno A; Flanigan PW; Bromberg PA
    J Pharmacol Exp Ther; 1976 Apr; 197(1):229-34. PubMed ID: 1263130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo viability studies of two additive solutions in the postthaw preservation of red cells held for 3 weeks at 4 degrees C.
    Moore GL; Hess JR; Ledford ME
    Transfusion; 1993 Sep; 33(9):709-12. PubMed ID: 8212114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automation of the glycerolization of red blood cells with the high-separation bowl in the Haemonetics ACP 215 instrument.
    Valeri CR; Ragno G; Van Houten P; Rose L; Rose M; Egozy Y; Popovsky MA
    Transfusion; 2005 Oct; 45(10):1621-7. PubMed ID: 16181213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
    Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
    J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the cryoprotective agents glycerol and hydroxyethyl starch on red blood cell ATP and 2,3-diphosphoglyceric acid levels.
    Rittmeyer IC; Nydegger UE
    Vox Sang; 1992; 62(3):141-5. PubMed ID: 1376947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-thaw storage at 4 degrees C of previously frozen red cells with retention of 2,3-DPG.
    Moore GL; Ledford ME; Mathewson PJ; Hankins DJ; Shah SB
    Vox Sang; 1987; 53(1):15-8. PubMed ID: 3660765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.